Cognitive, Swallowing & Speech Problems After Botox

Botulinum toxin is familiar territory for many speech-language pathologists- it's a medical treatment we learn about in controlled clinical contexts. What we are far less trained to recognize are patients who later develop unexplained changes in cognition, swallowing, or speech that don’t fit neatly into established diagnoses.

I became one of those patients in 2024 after receiving just 12 units of Xeomin cosmetically. Within weeks, I developed debilitating cognitive symptoms and severe swallowing difficulties. I lost 20 pounds in a single month and was unable to eat solid foods for nearly two months. Despite the severity of my symptoms, I was repeatedly dismissed and told nothing was wrong (even though my MBSS showed esophageal dysmotility and signals of severe dry mouth) - an experience many patients later described to me using nearly identical language.

Botulinum toxin is designed to act locally at the injection site by blocking neuromuscular transmission. However, clinical literature and regulatory warnings acknowledge that toxin effects may extend beyond the targeted muscle through local diffusion or systemic spread. When this occurs, symptoms can vary widely depending on the muscles and neural systems affected, ranging from localized weakness to broader changes in swallowing, voice, or cognitive function. As a result, patient presentations and recovery timelines can differ significantly from the expected duration of localized treatment effects.

On a mission to educate my peers about these symptoms, I have collected self-reported data from individuals reporting cognitive, swallowing, and speech changes following botulinum toxin injections. This dataset is observational and self-reported, but the clinical patterns that emerged are highly relevant to speech-language pathology, and also reflect what we know to be true about the effects of "toxin spread" per the manufacturers of these drugs. This article translates those patterns into neuroanatomy, clinical reasoning, and practical strategies for SLPs encountering patients whose symptoms may otherwise feel difficult to explain.

In this post:

• Clinical Analysis of Cognitive, Swallowing and Speech Impairments Reported After BoNT Injections

• Duration of Symptoms

• Clinical Considerations

• Clinical Management Strategies (How We Can Help)

• Conclusion

Clinical Analysis: Cognitive, Swallowing, and Speech Impairments Reported After BoNT Injections

(Preliminary Observational Dataset - Self-Reported Outcomes, accessed 2/25/26. Click here for the Google form that was used: https://forms.gle/7KyuQ7PNqEpUYjpW6)

1. Symptom Domain Prevalence

Symptom Domain	% of Sample
Cognitive impairment	91%
Swallowing difficulties	83%
Speaking/voice difficulties	66%

Clinical Interpretation

• High multi-system involvement rather than isolated local effects.

• Majority experienced impairments across multiple SLP-relevant domains.

• Pattern suggests systemic or distributed neuromuscular/cognitive effects rather than purely focal injection outcomes.

2. Cognitive-Linguistic Symptom Patterns

Most Frequently Reported Cognitive Symptoms

Symptom	% of Sample
Brain fog	91%
Slow processing speed	87%
Mental fatigue	83%
“Drugged/drunk” cognitive state	83%
Disorganized thinking	83%
Word-finding difficulty	80%
Short-term memory loss	72%
Attention impairment	68%
Long-term memory loss	40%
Depersonalization	4.3%

This cluster strongly resembles: Subcortical cognitive slowing profile

• Processing speed reduction

• Executive dysfunction

• Retrieval deficits

• Fatigability

  
  

Consistent with:

• diffuse neuromodulatory disruption

• central fatigue syndromes

• cholinergic dysfunction models (hypothesis only)

3. Swallowing Symptom Patterns (Dysphagia Phenotype)

   Most Commonly Reported Dysphagia Symptoms

Symptom	% of Sample
Dry mouth	74.5%
Globus sensation	66.0%
Sensation of food sticking	66.0%
Fear of choking during swallowing	57.4%
Frequent throat clearing	51.1%
Slowed tongue movement	48.9%
Choking sensation (with or without food)	44.7%
Coughing/choking during swallowing	44.7%
Heartburn	40.4%
Oropharyngeal spasms	31.9%

Findings suggest a mixed dysphagia presentation, potentially reflecting individual variation in the cranial nerve systems functionally affected.

Oral Phase Indicators

• Slowed lingual movement

• Xerostomia

• Bolus control complaints

Pharyngeal Phase Indicators

• Choking sensations

• Coughing during swallow

• Persistent globus sensation

  
  

Sensory Component

High prevalence of throat awareness and choking fear suggests possible sensorimotor disruption, not purely mechanical weakness.

4. Speech and Voice Findings

Most Commonly Reported Speech & Voice Symptoms

Symptom	% of Sample
Hoarse voice (Dysphonia)	57.4%
Articulation difficulty (Dysarthria)	55.3%
Reduced vocal projection	31.9%
Intermittent loss of voice	10.6%
Complete voice loss (Aphonia)	8.5%

Clinical Pattern

Consistent with a neuromuscular voice profile:

• Reduced projection

• Vocal fatigue

• Hoarseness

• Articulatory imprecision

Not typical of isolated structural vocal fold pathology.

5. Duration of Symptoms

Cognitive Difficulties

Duration	% of Respondents
1–6 months	8.7%
6–12 months	8.7%
12–24 months	4.3%

The majority reported symptoms lasting longer than these ranges or still ongoing.

Swallowing Difficulties

Duration	% of Respondents
1–6 months	31.7%
6–12 months	12.2%
12–24 months	7.3%

The rest reported symptoms lasting longer than these ranges or still ongoing.

Speaking / Voice Difficulties

Duration	% of Respondents
1–6 months	29.7%
6–12 months	13.5%
12–24 months	8.1%

The rest reported symptoms lasting longer than these ranges or still ongoing

Reported impairments frequently extended beyond expected and reported pharmacologic duration of localized toxin effect, indicating that systemic damage has a higher likelihood of taking many months and even years to heal.

6. Clinical Considerations

Cranial Nerves that Can Be Disrupted by Botulinum Toxin:

CN V - Trigeminal Nerve

Functions Relevant to Findings

• Mastication muscles

• Oral somatosensation

• Jaw stability

• Oral phase bolus control

  
  

Symptoms Suggesting CN V Contribution:

• Slowed oral control complaints

• Sensation of impaired chewing coordination

• Early swallowing difficulty without clear obstruction

  
  

Clinical Interpretation

Trigeminal motor disruption can produce:

• inefficient bolus preparation

• oral fatigue

• perceived swallowing difficulty even before pharyngeal involvement

  
  

SLPs may observe:

• prolonged oral transit

• reduced chewing endurance

CN VII — Facial Nerve

Functions

• Lip seal

• Buccal tension

• Salivary gland parasympathetic input

• Taste (anterior 2/3 tongue)

  
  

Dataset Signals

• High prevalence of dry mouth (74.5%)

• Articulation imprecision

• Speech fatigue

  
  

Clinical Significance

Reduced facial tone or salivary output may lead to:

• impaired bolus containment

• increased oral residue

• compensatory swallowing behaviors

  
  

Xerostomia alone can significantly alter bolus transport and swallow efficiency.

CN IX - Glossopharyngeal Nerve

Functions

• Oropharyngeal sensation

• Initiation of swallow reflex

• Stylopharyngeus elevation

• Posterior tongue sensory feedback

  
  

Dataset Indicators

• Globus sensation (66%)

• Food sticking sensation (66%)

• Choking fear without obstruction

  
  

Interpretation

Possible disruption of sensory feedback loops may cause:

• delayed swallow initiation perception

• abnormal throat awareness

• sensory mismatch between bolus transit and perception

  
  

Clinically, this may resemble:

• sensory dysphagia

• functional globus presentations

  
  

CN X - Vagus Nerve (Most Clinically Relevant)

Functions

• Pharyngeal constriction

• Laryngeal elevation

• Vocal fold movement

• Airway protection

• Autonomic regulation

  
  

Symptoms aligning with vagal involvement:

Symptom	%
Hoarse voice	57.4%
Reduced vocal projection	31.9%
Voice loss	10.6%
Choking/coughing with swallow	44.7%
Globus sensation	66%

Neurofunctional Interpretation

These symptoms resemble partial vagal motor inefficiency, particularly affecting:

• recurrent laryngeal nerve function

• superior laryngeal sensory input

• pharyngeal constrictor coordination

  
  

SLP-relevant manifestations:

• vocal fatigue; unable to project voice

• dry mouth

• reduced airway protection confidence

• persistent globus sensation throughout the day

• subtle dysphonia without paralysis.

CN XII - Hypoglossal Nerve

Functions

• Tongue movement

• Bolus propulsion

• Articulation precision

  
  

Dataset Indicators

• “Heavy tongue” sensation (48.9%)

• Articulation difficulty (55.3%)

  
  

Clinical Meaning

Hypoglossal involvement could explain:

• slowed lingual movement

• imprecise consonant production

• oral transit inefficiency

  
  

Often perceived by patients as: “My tongue doesn’t move right.”

Integrated Swallowing Model

Instead of isolated nerve dysfunction, the dataset suggests possible disruption across a cranial nerve network. When small inefficiencies occur across multiple nodes, patients experience:

• swallowing insecurity

• globus sensation

• choking anxiety

• voice fatigue

• articulation changes

even when instrumental exams appear largely normal.

Why Symptoms May Appear “Disproportionate” to Findings

SLPs frequently encounter cases where:

• FEES/VFSS findings are mild

• structural imaging is normal

• patient distress is high

  
  

This can occur when disruption affects:

• timing

• coordination, and

• sensory integration

rather than strength alone

Autonomic Component (Often Overlooked)

The vagus nerve regulates:

• salivary balance

• mucosal sensation

• laryngeal reflex sensitivity

High xerostomia rates suggest involvement of parasympathetic pathways, which can amplify dysphagia perception even with preserved mechanics.

Clinical Management Strategies for SLPs

BoNT-injured patients often present with:

• multi-domain symptoms

• fluctuating performance

• normal structural imaging

• high fatigue burden

• sensory complaints disproportionate to objective findings

  
  

Therefore: Management should prioritize functional efficiency, fatigue reduction, sensory regulation, and compensatory optimization rather than strength-based rehabilitation alone.

Cognitive-Linguistic Management Strategies

Common presentation:

• slowed processing speed

• mental fatigue

• word-finding difficulty

• reduced attention capacity

• “brain fog”

This profile resembles cognitive efficiency impairment, not classic aphasia.

Assessment Recommendations

SLPs may consider:

• functional cognitive assessment over impairment-only testing

• fatigue-aware testing sessions

• dynamic assessment across time of day

  
  

Helpful tools:

• Cognitive Linguistic Quick Test (CLQT)

• Functional Assessment of Verbal Reasoning

• discourse-level evaluation

  
  

Therapy Strategies

✅ Processing Speed Support

• Allow increased response latency

• Reduce time pressure

• Provide written + verbal input simultaneously

Clinical rationale: Reduced cognitive load improves accuracy more than repetition drills.

✅ Cognitive Pacing Model

Teach patients to:

• alternate cognitive effort and rest

• stop before symptom escalation (I typically tell patients to stop when they get to 70% of their maximum effort)

• track fatigue thresholds

Example: 15-20 minute cognitive activity blocks followed by recovery periods.

✅ Word-Finding Supports

• semantic feature analysis

• circumlocution training

• external cueing systems

Focus on communication success, not speed normalization

✅ Environmental Modifications

• reduced multitasking

• reduced screen time, especially late at night

• minimized background noise and artificial lights

• written follow-up instructions

• use of cell phone apps to use as reminders (short term memory issues are prevalent in this population)

  
  

Swallowing (Dysphagia) Management

Patients often report:

• globus sensation

• choking fear

• dry mouth

• slowed oral movement

• inconsistent swallow function

Important distinction: Many cases reflect coordination or sensory disruption, not frank weakness.

Evaluation Recommendations

Consider:

• VFSS or FEES when airway symptoms present; a small minority of BoNT-injured patients will require alternative feeding methods

• sensory-focused clinical swallow evaluation (be sure to check the gag reflex!)

• assessment across fatigue states

  
  

Document:

• timing abnormalities

• patient-reported effort

• fatigue progression during meals

  
  

Therapy Strategies

✅ Bolus Control Optimization

• smaller bites/sips

• alternating solids/liquids

• controlled pacing

Goal: reduce coordination demand.

✅ Sensory Enhancement Techniques

Useful when swallow initiation feels delayed:

• cold stimulation (ice water and popsicles)

• sour boluses (if appropriate)

• heightened sensory input

Rationale: Increased afferent feedback may improve swallow timing perception.

✅ Xerostomia Management

Recommend collaboration with medical providers and:

• frequent hydration with electrolytes

• saliva substitutes - I personally used "xylimelts" and Biotene products

• peppermint drops and gum (if safe)

• moist food textures - avoid dry, sticky, crunchy foods. I personally consumed a IDDSI level 5 diet for the first 2 months after my injury

Dryness alone can significantly impair bolus transport and swallow efficiency

✅ Reduce Hypervigilance Cycle

Patients often develop choking anxiety.

SLPs can:

• explain normal swallow physiology

• use biofeedback (FEES playback)

• reinforce preserved airway protection

Education reduces maladaptive guarding behaviors

Speech & Voice Management

• hoarseness

• reduced projection

• vocal fatigue

• articulatory imprecision

Often resembles reduced neuromuscular efficiency, not structural pathology

Therapy Strategies

✅ Vocal Efficiency Training

Focus on:

• resonant voice therapy principles

• reduced laryngeal strain

• forward resonance

• vagus nerve stimulation through humming

Avoid aggressive strengthening early (within first 6 months of injury)

✅ Breath Support Optimization

• coordinated breathing–phonation tasks

• shorter phrase length initially

• pacing strategies

Goal: reduce effort per utterance

✅ Articulation Clarity Techniques

• slowed speech rate: "SLOP" speech visual aid

• exaggerated articulation (temporarily)

• prosodic cueing

Improves intelligibility without increasing fatigue

✅ Energy Conservation for Communication

Teach:

• strategic communication timing

• prioritizing important conversations

• alternative and augmentative communication during fatigue peaks

Fatigue management is a primary intervention target

Counseling & Validation (Clinically Critical!)

Patients frequently report:

• being dismissed medically

• anxiety labels

• confusion about symptoms

  
  

The SLP role includes:

✅ validating functional experience

✅ explaining nervous-system coordination demands

✅ framing symptoms in understandable physiology

This alone often improves participation and outcomes

Red Flags for Referral or Collaboration

Refer or co-manage when observing:

• progressive weight loss (please note that significant weight loss of 10-20 lbs is extremely common in botulism. Encourage patients to eat whenever possible, and discourage any type of fasting, even when appetite is suppressed/absent)

• aspiration signs/symptoms

• persistent aphonia

• severe cognitive decline

  
  

Collaborate with:

• neurology

• ENT/laryngology

• GI specialists

• occupational therapy/physical therapy

  
  

Prognosis Communication

Helpful clinician phrasing: “Many coordination-based swallowing and communication problems improve gradually as the nervous system recalibrates. Our goal is to make eating and communication safer and less effortful during that process.”

Avoid absolute recovery timelines, as these vary greatly for individuals.

Conclusion

The stories reflected in this dataset describe not a single symptom, but a constellation affecting cognition, swallowing, and speech simultaneously.

Many patients present with significant functional impairment despite normal imaging or inconclusive medical evaluations, leaving them confused, frightened, and often dismissed.

Speech-language pathologists are uniquely positioned to help because our field focuses on function, coordination, and real-world participation. Even when mechanisms remain uncertain, thoughtful assessment, patient validation, and targeted compensatory strategies can restore safety, confidence, and quality of life.

Speech-language pathologists may also play a critical safety role simply by asking patients who present with these symptoms one critical question: whether they have recently received botulinum toxin injections.

Screening for BoNT exposure in patients presenting with new cognitive, swallowing, or voice changes can help guide appropriate evaluation and referral- and in some cases, may help prevent serious medical complications

The most important clinical interventions we provide often start with recognizing that our patients' experiences are real, and treating them with the compassion and dignity they deserve.